$1.73 Billion is the total value of PURA VIDA INVESTMENTS, LLC's 197 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SAREPTA THERAPEUTICS INCcall | $22,108,000 | +47.5% | 200,000 | 0.0% | 1.28% | +46.8% | ||
| ARK ETF TRput | $16,979,000 | -5.4% | 450,000 | 0.0% | 0.98% | -5.8% | ||
| APELLIS PHARMACEUTICALS INCcall | $13,660,000 | +51.0% | 200,000 | 0.0% | 0.79% | +50.5% | ||
| OCX | ONCOCYTE CORP | $13,181,000 | -18.9% | 18,056,274 | 0.0% | 0.76% | -19.1% | |
| SPDR SER TRcall | $7,869,000 | +6.8% | 99,200 | 0.0% | 0.46% | +6.3% | ||
| GERON CORPcall | $3,984,000 | +51.0% | 1,702,600 | 0.0% | 0.23% | +51.0% | ||
| TRICIDA INCcall | $3,334,000 | +8.3% | 318,100 | 0.0% | 0.19% | +7.8% | ||
| ATAI | ATAI LIFE SCIENCES NV | $2,389,000 | -9.1% | 721,824 | 0.0% | 0.14% | -9.8% | |
| AVITA MEDICAL INCcall | $2,372,000 | +10.9% | 450,000 | 0.0% | 0.14% | +10.5% | ||
| APEN | APOLLO ENDOSURGERY INC | $2,353,000 | +50.9% | 427,057 | 0.0% | 0.14% | +49.5% | |
| VERU INCcall | $2,304,000 | +1.9% | 200,000 | 0.0% | 0.13% | +1.5% | ||
| ANAVEX LIFE SCIENCES CORPcall | $2,064,000 | +3.1% | 200,000 | 0.0% | 0.12% | +2.6% | ||
| SCIENCE 37 HOLDINGS INC | $1,781,000 | -19.9% | 1,106,400 | 0.0% | 0.10% | -20.2% | ||
| NYXOAH S A | $1,423,000 | -34.9% | 221,949 | 0.0% | 0.08% | -35.4% | ||
| EXEL | EXELIXIS INC | $1,176,000 | -24.7% | 75,000 | 0.0% | 0.07% | -25.3% | |
| SONENDO INC | $1,095,000 | -37.8% | 1,023,424 | 0.0% | 0.06% | -38.2% | ||
| VSTM | VERASTEM INC | $854,000 | -26.7% | 1,004,272 | 0.0% | 0.05% | -27.9% | |
| HZNP | HORIZON THERAPEUTICS PUB L | $798,000 | -22.4% | 12,900 | 0.0% | 0.05% | -23.3% | |
| BLUEPRINT MEDICINES CORPput | $659,000 | +30.5% | 10,000 | 0.0% | 0.04% | +31.0% | ||
| IVERIC BIO INCput | $610,000 | +86.5% | 34,000 | 0.0% | 0.04% | +84.2% | ||
| MDVL | MEDAVAIL HOLDINGS INC | $554,000 | -49.3% | 714,120 | 0.0% | 0.03% | -49.2% | |
| GOSSAMER BIO INCnote 5.000% 6/0 | $516,000 | +38.0% | 5,000 | 0.0% | 0.03% | +36.4% | ||
| TRAVERE THERAPEUTICS INCnote 2.250% 3/0 | $511,000 | +1.8% | 5,000 | 0.0% | 0.03% | +3.4% | ||
| SVRA | SAVARA INC | $147,000 | +2.1% | 95,014 | 0.0% | 0.01% | +12.5% | |
| NEKTAR THERAPEUTICScall | $117,000 | -15.8% | 36,600 | 0.0% | 0.01% | -12.5% | ||
| TALKW | TALKSPACE INC*w exp 06/21/202 | $113,000 | -24.2% | 427,194 | 0.0% | 0.01% | -22.2% | |
| ROIVANT SCIENCES LTD*w exp 09/30/202 | $78,000 | -35.0% | 199,648 | 0.0% | 0.01% | -28.6% | ||
| SOMALOGIC INC*w exp 08/31/202 | $90,000 | -41.9% | 204,401 | 0.0% | 0.01% | -44.4% | ||
| RENOVACOR INC*w exp 99/99/999 | $12,000 | +50.0% | 150,632 | 0.0% | 0.00% | – | ||
| MAPSW | WM TECHNOLOGY INC*w exp 06/16/202 | $17,000 | -48.5% | 50,000 | 0.0% | 0.00% | -50.0% | |
| SPRINGBIG HOLDINGS INC*w exp 06/14/202 | $1,000 | 0.0% | 10,000 | 0.0% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ICU MED INC | 26 | Q2 2023 | 4.2% |
| NANOSTRING TECHNOLOGIES INC | 26 | Q2 2023 | 3.3% |
| VIEWRAY INC | 25 | Q2 2023 | 3.2% |
| LIVANOVA PLC | 23 | Q3 2023 | 3.8% |
| ALEXION PHARMACEUTICALS INC | 23 | Q1 2021 | 4.3% |
| INSPIRE MED SYS INC | 22 | Q3 2023 | 3.7% |
| BOSTON SCIENTIFIC CORP | 22 | Q3 2022 | 4.8% |
| INVACARE CORP | 22 | Q3 2021 | 2.8% |
| ESTABLISHMENT LABS HLDGS INC | 21 | Q3 2023 | 5.0% |
| INTERSECT ENT INC | 21 | Q2 2021 | 2.6% |
View PURA VIDA INVESTMENTS, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Stryve Foods Holdings, LLC | April 19, 2023 | 1,470,649 | 5.6% |
| ICAD INC | March 15, 2023 | 1,277,214 | 5.0% |
| ESTABLISHMENT LABS HOLDINGS INC. | February 14, 2023 | 1,002,767 | 4.1% |
| Pulmonx Corp | February 14, 2023 | 1,216,258 | 3.2% |
| Quotient LtdSold out | February 14, 2023 | 0 | 0.0% |
| Universe Pharmaceuticals INCSold out | February 14, 2023 | 0 | 0.0% |
| MedMen Enterprises, Inc. | April 29, 2022 | 139,755,072 | 21.4% |
| INVACARE CORPSold out | February 14, 2022 | 0 | 0.0% |
| MedAvail Holdings, Inc. | February 14, 2022 | 714,120 | 2.2% |
| TELA Bio, Inc. | February 14, 2022 | 564,120 | 3.9% |
View PURA VIDA INVESTMENTS, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2024-02-13 |
View PURA VIDA INVESTMENTS, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.